| 000 | 01697 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517130522.0 | ||
| 264 | 0 | _c20170829 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.13851 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHong, S N | |
| 245 | 0 | 0 |
_aRisk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c01 2017 |
||
| 300 |
_a253-263 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMycobacterium tuberculosis |
| 650 | 0 | 4 |
_aRepublic of Korea _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTuberculosis _xepidemiology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKim, H J | |
| 700 | 1 | _aKim, K H | |
| 700 | 1 | _aHan, S-J | |
| 700 | 1 | _aAhn, I M | |
| 700 | 1 | _aAhn, H S | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 45 _gno. 2 _gp. 253-263 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.13851 _zAvailable from publisher's website |
| 999 |
_c26680407 _d26680407 |
||